» Authors » Emily Greenspan

Emily Greenspan

Explore the profile of Emily Greenspan including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 6
Citations 67
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Bitterman D, Gensheimer M, Jaffray D, Pryma D, Jiang S, Morin O, et al.
JCO Clin Cancer Inform . 2023 Dec; 7:e2300136. PMID: 38055914
In August 2022, the Cancer Informatics for Cancer Centers brought together cancer informatics leaders for its biannual symposium, Precision Medicine Applications in Radiation Oncology, co-chaired by Quynh-Thu Le, MD (Stanford...
2.
Bebbington A, Chicchon A, Cuba N, Greenspan E, Hecht S, Bebbington D, et al.
Proc Natl Acad Sci U S A . 2020 Aug; 117(36):21829-21833. PMID: 32848071
No abstract available.
3.
Oktay M, Lee Y, Harney A, Farrell D, Kuhn N, Morris S, et al.
NPJ Breast Cancer . 2017 Jul; 1:15022. PMID: 28722033
Recent advances in cancer biology and the development of new research tools have enabled interrogations of single cells and cell-cell interactions. Emerging technologies are capable of revealing data on the...
4.
Pan J, Awoyemi B, Xuan Z, Vohra P, Wang H, Dyba M, et al.
Chem Res Toxicol . 2012 Nov; 25(12):2788-95. PMID: 23126278
Acrolein (Acr) is a ubiquitous environmental pollutant found in cigarette smoke and automobile exhaust. It can also be produced endogenously by oxidation of polyunsaturated fatty acids. The Acr-derived 1,N(2)-propanodeoxyguanosine (Acr-dG)...
5.
Dash C, Chung F, Rohan J, Greenspan E, Christopher P, Makambi K, et al.
BMC Complement Altern Med . 2012 Jul; 12:96. PMID: 22800470
Background: Chemoprevention crossover trials of tea can be more efficient than parallel designs but the attrition and compliance rates with such trials are unknown. Methods: Attrition (dropouts) and compliance with...
6.
Godman C, Joshi R, Tierney B, Greenspan E, Rasmussen T, Wang H, et al.
Cancer Biol Ther . 2008 Sep; 7(10):1570-80. PMID: 18769117
Histone deacetylase 3 (HDAC3) is overexpressed in approximately half of all colon adenocarcinomas. We took an RNAi approach to determine how HDAC3 influenced chromatin modifications and the expression of growth...